Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

HEALTHEQUITY, INC.
Next earnings Aug 31, 2026 · consensus $1.21 EPS, $352M rev
Last earnings +4.6% on 2026-05-28
HealthEquity's HSA model is compounding beautifully — revenue +9.5%, EPS +126%, 24.6% operating margin — riding custodial-cash yields and HSA adoption.
Sources: SEC EDGAR (CIK 0001428336, latest 10-Q filed 2026-05-28) · EODHD · analysis by claude-code · as of 6/21/2026, 8:57:30 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
Solid fundamentals at a roughly fair price — reasonable risk/reward at today's level.
HealthEquity is the leading HSA custodian, and FY2026 (ended January 2026) showcased the operating leverage of its recurring, fee-and-float model. Revenue grew 9.5% to $1.31B, but profitability exploded: net income jumped 122.5% to $215M, operating income nearly doubled (+98.6%) to $322M, and diluted EPS rose 125.7% to $2.46. That margin inflection — operating margin to 24.6% and gross margin to 69.5% — reflects the high incremental economics of administering tax-advantaged accounts plus rising yields on custodial HSA cash (the Enhanced Rates program). The multi-year trajectory is striking: from net losses in FY2022-23 to $55.7M, $96.7M and now $215M of net income.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | $757M | $862M | $1000M | $1.20B | $1.31B |
| Gross profit | $425M | $492M | $623M | $777M | $913M |
| Operating income | -$24.2M | $9.06M | $118M | $162M | $322M |
| Net income | -$44.3M | -$26.1M | $55.7M | $96.7M | $215M |
| Diluted EPS | -$0.53 | -$0.31 | $0.64 | $1.09 | $2.46 |
| Net margin | -5.9% | -3.0% | 5.6% | 8.1% | 16.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1482 tracked peers · median
1 buy · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 0 open-market buys · 3 sales
| 2026-05-29 | Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER | Sell | 3.14K @ $95.00 | $298K |
| 2026-05-28 | Wellborn Gayle Furgurson Director | Exercise | 2.44K @ $47.21 | $115K |
| 2026-05-28 | Wellborn Gayle Furgurson Director | Sell | 2.44K @ $90.00 | $220K |
| 2026-05-28 | Ladd Delano EVP, General Counsel | Sell | 7.50K @ $90.00 | $675K |
| 2026-04-06 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | Tax | 2.56K @ $83.84 | $215K |
| 2026-04-06 | Ladd Delano EVP, General Counsel | Tax | 2.48K @ $83.84 | $208K |
| 2026-04-06 | Fiore Michael Henry EVP, CHIEF COMMERCIAL OFFICER | Tax | 3.38K @ $83.84 | $283K |
| 2026-04-06 | Rosner Elimelech EVP, CHIEF TECHNOLOGY OFFICER | Tax | 4.77K @ $83.84 | $400K |
| 2026-04-06 | Lucania James M EVP & CFO | Tax | 4.39K @ $83.84 | $368K |